Linda Palczuk

Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE.

Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017.